July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Homeostatic Role for GPR158 in Modulating Intraocular Pressure (IOP)
Author Affiliations & Notes
  • Tatsuo Itakura
    Keck School of Medicine of USC, University of Southern California, Los Angeles, California, United States
  • Andrew Webster
    Keck School of Medicine of USC, University of Southern California, Los Angeles, California, United States
  • Jose M Gonzalez
    Doheny Eye Institute , Los Angeles, California, United States
  • James C H Tan
    Doheny Eye Institute , Los Angeles, California, United States
  • Maria Sibug-Saber
    Keck School of Medicine of USC, University of Southern California, Los Angeles, California, United States
  • Cheryl Mae Craft
    Ophthalmology & Cell & Neurobiology, Keck Med. Sch. of USC & USC ROSKI EYE INSTITUTE, Los Angeles, California, United States
  • Janice A Vranka
    Ophthalmology - CERES, Casey Eye Institute-OHSU, Portland, Oregon, United States
  • Ted S Acott
    Ophthalmology - CERES, Casey Eye Institute-OHSU, Portland, Oregon, United States
  • W Daniel Stamer
    Ophthalmology, Duke University, Durham, North Carolina, United States
  • Kirill A Martemyanov
    Department of Neuroscience, Scripps Research Institute, Jupiter, Florida, United States
  • M Elizabeth Fini
    Keck School of Medicine of USC, University of Southern California, Los Angeles, California, United States
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 4724. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tatsuo Itakura, Andrew Webster, Jose M Gonzalez, James C H Tan, Maria Sibug-Saber, Cheryl Mae Craft, Janice A Vranka, Ted S Acott, W Daniel Stamer, Kirill A Martemyanov, M Elizabeth Fini; Homeostatic Role for GPR158 in Modulating Intraocular Pressure (IOP). Invest. Ophthalmol. Vis. Sci. 2018;59(9):4724.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : GPR158 is a glutamate family GPCR with unconventional activities, identified in screens for proteins interacting with RGS7 (PMID: 22689652) and genes associated with steroid-induced ocular hypertension (PMID: 27666015). GPR158 is expressed in trabecular meshwork (TBM) cells and expression is induced by glucocorticoid stress hormones (PMID: 23451275). Here we investigated possible stress-associated effects of GPR158 on IOP.

Methods : GPR158 was placed under control of the tet-on system in a lentivirus expression vector (pSLIK), then the construct was stably infected into immortalized human TBM cells (TM-1). The transgene was induced by doxycycline (100 ng/ml). A competitive ELISA was used for cAMP quantification (Thermo Fisher Scientific, MA). GPR158 knockout (KO) mice (KO Mouse Project repository, Davis, CA) were bred onto the C57Bl/6J background. Mice were anesthetized with isoflurane, 5 min before IOP measurement by Tonolab (Icare, NC). Epinephrine at 109 μM was applied topically (2 μL) to the right eye of GPR158 KO or wild type mice, and then IOP was measured at 30, 60 and 90 min and compared to the untreated eye.

Results : TM-1 cell treatment with epinephrine (adrenergic receptor ligand) at 250 μM induced a spike in the cAMP level. Epinephrine administration with GPR158 transgene induction enhanced the cAMP level by 25.2% over controls ) after 30 min (p<0.025, n=3, ANOVA), 17.6% after 60 min (p<0.04, n=3, ANOVA) and 18.6% after 180 min (p<0.01, n=3, ANOVA). GPR158 transgene induction alone had no effect on cAMP. Epinephrine treatment decreased IOP by 4.19 mmHg in wild type mice at 60 min (p<0.02; n=3, paired t-test). In contrast, epinephrine treatment had little or no effect on IOP in GPR158 KO mice. No difference in IOP was apparent between wildtype and KO mice at 3-months of age (GPR158+/+ = 12.1 mmHg, GPR158-/- = 11.5 mmHg; p=0.58, n=3, t-test) and 9-month of age (GPR158+/+ = 15.8 mmHg, GPR158-/- = 18.5 mmHg; p=0.18, n=3, t-test). However, by 6-months of age, IOP was significantly higher in wild type than KO mice (GPR158+/+ = 14.15 mmHg, n=3; GPR158-/- = 11.78 mmHg, p<0.008, n=3, t-test).

Conclusions : GPR158 cooperates with adrenergic receptors to enhance cAMP production in TM-1 cells in response to stress. KO mice are insensitive to epinephrine’s IOP-lowering effect. Finding GPR158 ligands might enhance current therapeutics for reducing IOP of glaucoma patient.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×